These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33503867)

  • 1. Inflammatory Chemokines in Atherosclerosis.
    Gencer S; Evans BR; van der Vorst EPC; Döring Y; Weber C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33503867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in atherosclerosis: proceedings resumed.
    Zernecke A; Weber C
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):742-50. PubMed ID: 24436368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in the vascular inflammatory response of atherosclerosis.
    Zernecke A; Weber C
    Cardiovasc Res; 2010 May; 86(2):192-201. PubMed ID: 20007309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases.
    Nagar N; Naidu G; Panda SK; Gulati K; Singh RP; Poluri KM
    Mech Ageing Dev; 2024 Aug; 220():111944. PubMed ID: 38782074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the chemokine network in atherosclerosis.
    Yan Y; Thakur M; van der Vorst EPC; Weber C; Döring Y
    Atherosclerosis; 2021 Aug; 330():95-106. PubMed ID: 34247863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of atherosclerotic plaque inflammation.
    Bäck M; Weber C; Lutgens E
    J Intern Med; 2015 Nov; 278(5):462-82. PubMed ID: 25823439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report.
    van der Vorst EPC; Mandl M; Müller M; Neideck C; Jansen Y; Hristov M; Gencer S; Peters LJF; Meiler S; Feld M; Geiselhöringer AL; de Jong RJ; Ohnmacht C; Noels H; Soehnlein O; Drechsler M; Weber C; Döring Y
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):685-693. PubMed ID: 30786742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques.
    Papadopoulou C; Corrigall V; Taylor PR; Poston RN
    Cytokine; 2008 Aug; 43(2):181-6. PubMed ID: 18579408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and atherosclerosis.
    Sheikine Y; Hansson GK
    Ann Med; 2004; 36(2):98-118. PubMed ID: 15119830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mediators in atherosclerotic vascular disease.
    Zernecke A; Weber C
    Basic Res Cardiol; 2005 Mar; 100(2):93-101. PubMed ID: 15645164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue.
    Surmi BK; Hasty AH
    Vascul Pharmacol; 2010; 52(1-2):27-36. PubMed ID: 20026286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and microRNAs in atherosclerosis.
    Hartmann P; Schober A; Weber C
    Cell Mol Life Sci; 2015 Sep; 72(17):3253-66. PubMed ID: 26001902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.
    Sato K; Yoshizawa H; Seki T; Shirai R; Yamashita T; Okano T; Shibata K; Wakamatsu MJ; Mori Y; Morita T; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
    Clin Sci (Lond); 2019 Aug; 133(16):1779-1796. PubMed ID: 31399499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling.
    Patel J; McNeill E; Douglas G; Hale AB; de Bono J; Lee R; Iqbal AJ; Regan-Komito D; Stylianou E; Greaves DR; Channon KM
    Nat Commun; 2015 Mar; 6():6614. PubMed ID: 25782711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of chemokine interactions in atherosclerosis.
    Koenen RR; Weber C
    Nat Rev Drug Discov; 2010 Feb; 9(2):141-53. PubMed ID: 20118962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.